A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_sessionca22bce6bda900593a2c8abcec2171f6c87755bc): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global CGT CDMO Market Insights, Forecast to 2034

img

Global CGT CDMO Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global CGT CDMO Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal CGT CDMO Market
Global CGT CDMO market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, CGT CDMO industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global CGT CDMO market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global CGT CDMO market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


WuXi AppTec
OBiO
GenScript
Porton
Lonza
Pharmaron
Catalent
Thermo Fisher
Oxford Biomedica (OXB)
Asymchem
Rentschler Biopharma
Novartis
Segment by Type
Immune Cells
Stem Cells
Viral Vectors
Plasmid DNA

Segment by Application


Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Hospital
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, CGT CDMO introduction, etc. CGT CDMO Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of CGT CDMO
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CGT CDMO Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Immune Cells
1.2.3 Stem Cells
1.2.4 Viral Vectors
1.2.5 Plasmid DNA
1.3 Market by Application
1.3.1 Global CGT CDMO Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Research and Academic Institutions
1.3.4 Hospital
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CGT CDMO Market Perspective (2018-2033)
2.2 Global CGT CDMO Growth Trends by Region
2.2.1 CGT CDMO Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 CGT CDMO Historic Market Size by Region (2018-2023)
2.2.3 CGT CDMO Forecasted Market Size by Region (2024-2033)
2.3 CGT CDMO Market Dynamics
2.3.1 CGT CDMO Industry Trends
2.3.2 CGT CDMO Market Drivers
2.3.3 CGT CDMO Market Challenges
2.3.4 CGT CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue CGT CDMO by Players
3.1.1 Global CGT CDMO Revenue by Players (2018-2023)
3.1.2 Global CGT CDMO Revenue Market Share by Players (2018-2023)
3.2 Global CGT CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of CGT CDMO, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global CGT CDMO Market Concentration Ratio
3.4.1 Global CGT CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CGT CDMO Revenue in 2022
3.5 Global Key Players of CGT CDMO Head office and Area Served
3.6 Global Key Players of CGT CDMO, Product and Application
3.7 Global Key Players of CGT CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CGT CDMO Breakdown Data by Type
4.1 Global CGT CDMO Historic Market Size by Type (2018-2023)
4.2 Global CGT CDMO Forecasted Market Size by Type (2024-2033)
5 CGT CDMO Breakdown Data by Application
5.1 Global CGT CDMO Historic Market Size by Application (2018-2023)
5.2 Global CGT CDMO Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America CGT CDMO Market Size (2018-2033)
6.2 North America CGT CDMO Market Size by Type
6.2.1 North America CGT CDMO Market Size by Type (2018-2023)
6.2.2 North America CGT CDMO Market Size by Type (2024-2033)
6.2.3 North America CGT CDMO Market Share by Type (2018-2033)
6.3 North America CGT CDMO Market Size by Application
6.3.1 North America CGT CDMO Market Size by Application (2018-2023)
6.3.2 North America CGT CDMO Market Size by Application (2024-2033)
6.3.3 North America CGT CDMO Market Share by Application (2018-2033)
6.4 North America CGT CDMO Market Size by Country
6.4.1 North America CGT CDMO Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America CGT CDMO Market Size by Country (2018-2023)
6.4.3 North America CGT CDMO Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe CGT CDMO Market Size (2018-2033)
7.2 Europe CGT CDMO Market Size by Type
7.2.1 Europe CGT CDMO Market Size by Type (2018-2023)
7.2.2 Europe CGT CDMO Market Size by Type (2024-2033)
7.2.3 Europe CGT CDMO Market Share by Type (2018-2033)
7.3 Europe CGT CDMO Market Size by Application
7.3.1 Europe CGT CDMO Market Size by Application (2018-2023)
7.3.2 Europe CGT CDMO Market Size by Application (2024-2033)
7.3.3 Europe CGT CDMO Market Share by Application (2018-2033)
7.4 Europe CGT CDMO Market Size by Country
7.4.1 Europe CGT CDMO Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe CGT CDMO Market Size by Country (2018-2023)
7.4.3 Europe CGT CDMO Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China CGT CDMO Market Size (2018-2033)
8.2 China CGT CDMO Market Size by Type
8.2.1 China CGT CDMO Market Size by Type (2018-2023)
8.2.2 China CGT CDMO Market Size by Type (2024-2033)
8.2.3 China CGT CDMO Market Share by Type (2018-2033)
8.3 China CGT CDMO Market Size by Application
8.3.1 China CGT CDMO Market Size by Application (2018-2023)
8.3.2 China CGT CDMO Market Size by Application (2024-2033)
8.3.3 China CGT CDMO Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia CGT CDMO Market Size (2018-2033)
9.2 Asia CGT CDMO Market Size by Type
9.2.1 Asia CGT CDMO Market Size by Type (2018-2023)
9.2.2 Asia CGT CDMO Market Size by Type (2024-2033)
9.2.3 Asia CGT CDMO Market Share by Type (2018-2033)
9.3 Asia CGT CDMO Market Size by Application
9.3.1 Asia CGT CDMO Market Size by Application (2018-2023)
9.3.2 Asia CGT CDMO Market Size by Application (2024-2033)
9.3.3 Asia CGT CDMO Market Share by Application (2018-2033)
9.4 Asia CGT CDMO Market Size by Region
9.4.1 Asia CGT CDMO Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia CGT CDMO Market Size by Region (2018-2023)
9.4.3 Asia CGT CDMO Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America CGT CDMO Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America CGT CDMO Market Size by Type
10.2.1 Middle East, Africa, and Latin America CGT CDMO Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America CGT CDMO Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America CGT CDMO Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America CGT CDMO Market Size by Application
10.3.1 Middle East, Africa, and Latin America CGT CDMO Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America CGT CDMO Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America CGT CDMO Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America CGT CDMO Market Size by Country
10.4.1 Middle East, Africa, and Latin America CGT CDMO Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America CGT CDMO Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America CGT CDMO Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 WuXi AppTec
11.1.1 WuXi AppTec Company Details
11.1.2 WuXi AppTec Business Overview
11.1.3 WuXi AppTec CGT CDMO Introduction
11.1.4 WuXi AppTec Revenue in CGT CDMO Business (2018-2023)
11.1.5 WuXi AppTec Recent Developments
11.2 OBiO
11.2.1 OBiO Company Details
11.2.2 OBiO Business Overview
11.2.3 OBiO CGT CDMO Introduction
11.2.4 OBiO Revenue in CGT CDMO Business (2018-2023)
11.2.5 OBiO Recent Developments
11.3 GenScript
11.3.1 GenScript Company Details
11.3.2 GenScript Business Overview
11.3.3 GenScript CGT CDMO Introduction
11.3.4 GenScript Revenue in CGT CDMO Business (2018-2023)
11.3.5 GenScript Recent Developments
11.4 Porton
11.4.1 Porton Company Details
11.4.2 Porton Business Overview
11.4.3 Porton CGT CDMO Introduction
11.4.4 Porton Revenue in CGT CDMO Business (2018-2023)
11.4.5 Porton Recent Developments
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza CGT CDMO Introduction
11.5.4 Lonza Revenue in CGT CDMO Business (2018-2023)
11.5.5 Lonza Recent Developments
11.6 Pharmaron
11.6.1 Pharmaron Company Details
11.6.2 Pharmaron Business Overview
11.6.3 Pharmaron CGT CDMO Introduction
11.6.4 Pharmaron Revenue in CGT CDMO Business (2018-2023)
11.6.5 Pharmaron Recent Developments
11.7 Catalent
11.7.1 Catalent Company Details
11.7.2 Catalent Business Overview
11.7.3 Catalent CGT CDMO Introduction
11.7.4 Catalent Revenue in CGT CDMO Business (2018-2023)
11.7.5 Catalent Recent Developments
11.8 Thermo Fisher
11.8.1 Thermo Fisher Company Details
11.8.2 Thermo Fisher Business Overview
11.8.3 Thermo Fisher CGT CDMO Introduction
11.8.4 Thermo Fisher Revenue in CGT CDMO Business (2018-2023)
11.8.5 Thermo Fisher Recent Developments
11.9 Oxford Biomedica (OXB)
11.9.1 Oxford Biomedica (OXB) Company Details
11.9.2 Oxford Biomedica (OXB) Business Overview
11.9.3 Oxford Biomedica (OXB) CGT CDMO Introduction
11.9.4 Oxford Biomedica (OXB) Revenue in CGT CDMO Business (2018-2023)
11.9.5 Oxford Biomedica (OXB) Recent Developments
11.10 Asymchem
11.10.1 Asymchem Company Details
11.10.2 Asymchem Business Overview
11.10.3 Asymchem CGT CDMO Introduction
11.10.4 Asymchem Revenue in CGT CDMO Business (2018-2023)
11.10.5 Asymchem Recent Developments
11.11 Rentschler Biopharma
11.11.1 Rentschler Biopharma Company Details
11.11.2 Rentschler Biopharma Business Overview
11.11.3 Rentschler Biopharma CGT CDMO Introduction
11.11.4 Rentschler Biopharma Revenue in CGT CDMO Business (2018-2023)
11.11.5 Rentschler Biopharma Recent Developments
11.12 Novartis
11.12.1 Novartis Company Details
11.12.2 Novartis Business Overview
11.12.3 Novartis CGT CDMO Introduction
11.12.4 Novartis Revenue in CGT CDMO Business (2018-2023)
11.12.5 Novartis Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CGT CDMO Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Immune Cells
Table 3. Key Players of Stem Cells
Table 4. Key Players of Viral Vectors
Table 5. Key Players of Plasmid DNA
Table 6. Global CGT CDMO Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global CGT CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global CGT CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global CGT CDMO Market Share by Region (2018-2023)
Table 10. Global CGT CDMO Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global CGT CDMO Market Share by Region (2024-2033)
Table 12. CGT CDMO Market Trends
Table 13. CGT CDMO Market Drivers
Table 14. CGT CDMO Market Challenges
Table 15. CGT CDMO Market Restraints
Table 16. Global CGT CDMO Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global CGT CDMO Revenue Share by Players (2018-2023)
Table 18. Global Top CGT CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CGT CDMO as of 2022)
Table 19. Global CGT CDMO Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by CGT CDMO Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of CGT CDMO, Headquarters and Area Served
Table 22. Global Key Players of CGT CDMO, Product and Application
Table 23. Global Key Players of CGT CDMO, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global CGT CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global CGT CDMO Revenue Market Share by Type (2018-2023)
Table 27. Global CGT CDMO Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global CGT CDMO Revenue Market Share by Type (2024-2033)
Table 29. Global CGT CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global CGT CDMO Revenue Share by Application (2018-2023)
Table 31. Global CGT CDMO Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global CGT CDMO Revenue Share by Application (2024-2033)
Table 33. North America CGT CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America CGT CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America CGT CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America CGT CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America CGT CDMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America CGT CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America CGT CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe CGT CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe CGT CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe CGT CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe CGT CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe CGT CDMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe CGT CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe CGT CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 47. China CGT CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 48. China CGT CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 49. China CGT CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 50. China CGT CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia CGT CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia CGT CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia CGT CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia CGT CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia CGT CDMO Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia CGT CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia CGT CDMO Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America CGT CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America CGT CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America CGT CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America CGT CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America CGT CDMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America CGT CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America CGT CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 65. WuXi AppTec Company Details
Table 66. WuXi AppTec Business Overview
Table 67. WuXi AppTec CGT CDMO Product
Table 68. WuXi AppTec Revenue in CGT CDMO Business (2018-2023) & (US$ Million)
Table 69. WuXi AppTec Recent Developments
Table 70. OBiO Company Details
Table 71. OBiO Business Overview
Table 72. OBiO CGT CDMO Product
Table 73. OBiO Revenue in CGT CDMO Business (2018-2023) & (US$ Million)
Table 74. OBiO Recent Developments
Table 75. GenScript Company Details
Table 76. GenScript Business Overview
Table 77. GenScript CGT CDMO Product
Table 78. GenScript Revenue in CGT CDMO Business (2018-2023) & (US$ Million)
Table 79. GenScript Recent Developments
Table 80. Porton Company Details
Table 81. Porton Business Overview
Table 82. Porton CGT CDMO Product
Table 83. Porton Revenue in CGT CDMO Business (2018-2023) & (US$ Million)
Table 84. Porton Recent Developments
Table 85. Lonza Company Details
Table 86. Lonza Business Overview
Table 87. Lonza CGT CDMO Product
Table 88. Lonza Revenue in CGT CDMO Business (2018-2023) & (US$ Million)
Table 89. Lonza Recent Developments
Table 90. Pharmaron Company Details
Table 91. Pharmaron Business Overview
Table 92. Pharmaron CGT CDMO Product
Table 93. Pharmaron Revenue in CGT CDMO Business (2018-2023) & (US$ Million)
Table 94. Pharmaron Recent Developments
Table 95. Catalent Company Details
Table 96. Catalent Business Overview
Table 97. Catalent CGT CDMO Product
Table 98. Catalent Revenue in CGT CDMO Business (2018-2023) & (US$ Million)
Table 99. Catalent Recent Developments
Table 100. Thermo Fisher Company Details
Table 101. Thermo Fisher Business Overview
Table 102. Thermo Fisher CGT CDMO Product
Table 103. Thermo Fisher Revenue in CGT CDMO Business (2018-2023) & (US$ Million)
Table 104. Thermo Fisher Recent Developments
Table 105. Oxford Biomedica (OXB) Company Details
Table 106. Oxford Biomedica (OXB) Business Overview
Table 107. Oxford Biomedica (OXB) CGT CDMO Product
Table 108. Oxford Biomedica (OXB) Revenue in CGT CDMO Business (2018-2023) & (US$ Million)
Table 109. Oxford Biomedica (OXB) Recent Developments
Table 110. Asymchem Company Details
Table 111. Asymchem Business Overview
Table 112. Asymchem CGT CDMO Product
Table 113. Asymchem Revenue in CGT CDMO Business (2018-2023) & (US$ Million)
Table 114. Asymchem Recent Developments
Table 115. Rentschler Biopharma Company Details
Table 116. Rentschler Biopharma Business Overview
Table 117. Rentschler Biopharma CGT CDMO Product
Table 118. Rentschler Biopharma Revenue in CGT CDMO Business (2018-2023) & (US$ Million)
Table 119. Rentschler Biopharma Recent Developments
Table 120. Novartis Company Details
Table 121. Novartis Business Overview
Table 122. Novartis CGT CDMO Product
Table 123. Novartis Revenue in CGT CDMO Business (2018-2023) & (US$ Million)
Table 124. Novartis Recent Developments
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CGT CDMO Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global CGT CDMO Market Share by Type: 2022 VS 2033
Figure 3. Immune Cells Features
Figure 4. Stem Cells Features
Figure 5. Viral Vectors Features
Figure 6. Plasmid DNA Features
Figure 7. Global CGT CDMO Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global CGT CDMO Market Share by Application: 2022 VS 2033
Figure 9. Pharmaceutical and Biotechnology Companies Case Studies
Figure 10. Research and Academic Institutions Case Studies
Figure 11. Hospital Case Studies
Figure 12. Others Case Studies
Figure 13. CGT CDMO Report Years Considered
Figure 14. Global CGT CDMO Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global CGT CDMO Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global CGT CDMO Market Share by Region: 2022 VS 2033
Figure 17. Global CGT CDMO Market Share by Players in 2022
Figure 18. Global Top CGT CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CGT CDMO as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by CGT CDMO Revenue in 2022
Figure 20. North America CGT CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America CGT CDMO Market Share by Type (2018-2033)
Figure 22. North America CGT CDMO Market Share by Application (2018-2033)
Figure 23. North America CGT CDMO Market Share by Country (2018-2033)
Figure 24. United States CGT CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada CGT CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe CGT CDMO Market Size YoY (2018-2033) & (US$ Million)
Figure 27. Europe CGT CDMO Market Share by Type (2018-2033)
Figure 28. Europe CGT CDMO Market Share by Application (2018-2033)
Figure 29. Europe CGT CDMO Market Share by Country (2018-2033)
Figure 30. Germany CGT CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France CGT CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. CGT CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy CGT CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia CGT CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries CGT CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. China CGT CDMO Market Size YoY (2018-2033) & (US$ Million)
Figure 37. China CGT CDMO Market Share by Type (2018-2033)
Figure 38. China CGT CDMO Market Share by Application (2018-2033)
Figure 39. Asia CGT CDMO Market Size YoY (2018-2033) & (US$ Million)
Figure 40. Asia CGT CDMO Market Share by Type (2018-2033)
Figure 41. Asia CGT CDMO Market Share by Application (2018-2033)
Figure 42. Asia CGT CDMO Market Share by Region (2018-2033)
Figure 43. Japan CGT CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. South Korea CGT CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. China Taiwan CGT CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Southeast Asia CGT CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. India CGT CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Australia CGT CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America CGT CDMO Market Size YoY (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America CGT CDMO Market Share by Type (2018-2033)
Figure 51. Middle East, Africa, and Latin America CGT CDMO Market Share by Application (2018-2033)
Figure 52. Middle East, Africa, and Latin America CGT CDMO Market Share by Country (2018-2033)
Figure 53. Brazil CGT CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Mexico CGT CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Turkey CGT CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia CGT CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Israel CGT CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. GCC Countries CGT CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. WuXi AppTec Revenue Growth Rate in CGT CDMO Business (2018-2023)
Figure 60. OBiO Revenue Growth Rate in CGT CDMO Business (2018-2023)
Figure 61. GenScript Revenue Growth Rate in CGT CDMO Business (2018-2023)
Figure 62. Porton Revenue Growth Rate in CGT CDMO Business (2018-2023)
Figure 63. Lonza Revenue Growth Rate in CGT CDMO Business (2018-2023)
Figure 64. Pharmaron Revenue Growth Rate in CGT CDMO Business (2018-2023)
Figure 65. Catalent Revenue Growth Rate in CGT CDMO Business (2018-2023)
Figure 66. Thermo Fisher Revenue Growth Rate in CGT CDMO Business (2018-2023)
Figure 67. Oxford Biomedica (OXB) Revenue Growth Rate in CGT CDMO Business (2018-2023)
Figure 68. Asymchem Revenue Growth Rate in CGT CDMO Business (2018-2023)
Figure 69. Rentschler Biopharma Revenue Growth Rate in CGT CDMO Business (2018-2023)
Figure 70. Novartis Revenue Growth Rate in CGT CDMO Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries